Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Nihon Kohden Corporation ( (JP:6849) ) is now available.
Nihon Kohden has reported the application results for its Career Change Support Program and Next Career Support Program for employees in Japan, which were offered to staff in its Abbott-related business and to eligible older employees at the parent company and select group firms. A total of 152 employees applied, below the earlier estimate of about 200, with retirements scheduled between late January and the end of March 2026.
The company recorded approximately ¥2.4 billion in extraordinary losses in the third quarter of FY2025 due to extra payments for early retirements under these programs, an impact already reflected in its current earnings forecast. From FY2026, however, Nihon Kohden expects selling, general and administrative expenses to decline by around ¥1.8 billion, indicating a structural cost reduction that could support profitability and operational efficiency over the longer term.
The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1769.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation is a Japan-based medical device manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The company develops and supplies healthcare equipment and related technologies, with operations spanning its own business and those of certain domestic group companies, including activities linked to an Abbott-related business in Japan.
Average Trading Volume: 616,636
Technical Sentiment Signal: Buy
Current Market Cap: Yen281.9B
For a thorough assessment of 6849 stock, go to TipRanks’ Stock Analysis page.